Clover Health Investments, Corp.

CLOVNASDAQHealthcare● Active

$3.93

+$0.10(+2.61%)

Market Cap$2.0B

P/E Ratio—

52W High$4.23

52W Low$1.58

Avg Volume6.5M

Open$3.88

Beta2.48

Free Cash Flow Financials Revenue

Clover Health Investments, Corp. (CLOV) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CLOV · free cash flow · updated Jun 8, 2026

Core FCF metrics

CLOV · FCF · TTM · margin & CAGR

Free cash flow was −$69.0M for FY2025 (fiscal year ending 2025-12-31), down 307.2% year-over-year The FCF margin was -3.6%.

FY2025 Free Cash Flow−$69.0M▼ -307.2% YoY

Trailing 12M (TTM)$54.5MTrailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-3.6%−$69.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CLOV · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$66.9M(2M)−$69.0M▼ 307.2%-3.6%

FY2024$34.8M(2M)$33.3M▲ +128.6%2.4%

FY2023−$115.9M(1M)−$116.5M▲ +44.1%-9.2%

FY2022−$203.9M(4M)−$208.4M▲ +26.4%-19.0%

FY2021−$282.3M(1M)−$283.0M▼ 137.5%-19.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CLOV · P/FCF · FCF yield · FCF per share

Clover Health Investments, Corp. (CLOV) trades at a FCF yield of 2.68% and a price-to-free-cash-flow ratio of 35.7x. FCF per share stands at $0.11, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

2.68%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.11

TTM FCF ÷ Shares Outstanding

Price / FCF

x35.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x34.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CLOV · cash flow statement · operating / investing / financing

For FY2025, Clover Health Investments, Corp. generated −$66.9M in operating cash flow and spent 2M in capital expenditures, yielding −$69.0M in free cash flow.

Operating Activities

−$66.9M

Cash from core business operations

2025-12-31

Investing Activities

+$4.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$53.4M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$66.9M) − |CapEx| (2M) = FCF (−$69.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CLOV vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Clover Health Investments, Corp.YOU

CLOV

−$69.0M-307.2%-3.6%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Clover Health Investments, Corp. (CLOV) reported free cash flow of −$69.0M for FY2025 (fiscal year ending 2025-12-31), down 307.2% year-over-year. The FCF margin was -3.6%.

Based on available data, Clover Health Investments, Corp. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $33.3M in FY2024.

Clover Health Investments, Corp.'s FCF yield is 2.68% and price-to-FCF ratio is 35.7x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CLOV free cash flow · 8 questions

Clover Health Investments, Corp. free cash flow was −$69.0M for FY2025, down 307.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $54.5M.

CLOV free cash flowCLOV FCFCLOV FCF 2025CLOV free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Clover Health Investments, Corp. · Clover Health Investments, Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026